Life Sciences

TrialAssure Releases Anonymize DS To Automate Clinical Trail Data

CANTON - TrialAssure – a software company focused on developing clinical trial transparency tools – has released Anonymize DS, the all-new software-as-a-service application that uses automation to anonymize sponsor’s clinical trial data. “As one of the first groups to automate the anonymization of datasets, our developers heard first-hand feedback from industry users during the limited

By |2019-09-29T20:08:58-04:00September 29th, 2019|As-A-Service, Life Sciences, Life Sciences/Biotech|

Henry Ford e-Home Care Cuts Hospital Readmissions

DETROIT—Henry Ford e-Home Care has announced a significant reduction in hospital readmissions for patients receiving telehealth care via Henry Ford’s e-Home Care program. Achieving monthly readmission rates as low as 7 percent, Henry Ford e-Home Care has reduced its average hospital readmission rate for the first six months of 2019 by 45 percent compared with

By |2019-09-22T12:59:07-04:00September 22nd, 2019|Life Sciences, Life Sciences/Biotech|

Cancer Screening Startup Raises $22 Million

ROYAL OAK—OncoCell MDx Inc., a startup incubated at Harvard University to develop sophisticated cancer diagnosis from a simple blood sample, has raised $22.2 million in a Preferred Series B funding round. The financing was led by San Francisco-based Savitr Capital LLC, with participation from existing investors. OncoCell began operations in 2013, and since then has

By |2019-09-14T15:01:19-04:00September 14th, 2019|Life Sciences|

Genomenon Partners With Chinese To Sell Mastermind Genomic Search Engine

ANN ARBOR - Genomenon, Inc., and Shanghai Shanyi Biological Technology Co., Ltd have formed a partnership to provide Genomenon’s leading Mastermind Genomic Search Engine to clinical laboratory customers in China. Genomenon’s Mastermind is a genomic search engine wiith nearly 3,500 users in over 100 countries, becoming the search engine of choice when researching patient variants

By |2019-08-20T20:10:00-04:00August 20th, 2019|Life Sciences, Life Sciences/Biotech|

Ophthalmic Startup Gets $5 Million Investment To Complete Phase 2 Clinical Trials

FARMINGTON HILLS—Ocuphire Pharma Inc., a clinical-stage pharmaceutical company developing therapies to treat patients with a variety of ophthalmic disorders, announced that it has closed on over $5 million of financing. Investors include Jackson-based RBI Opportunities Fund, Douglas, Mich.-based Belle Capital Fund, Grand Rapids-based Grand Angels Fund, Farmington Hills-based First Capital Fund, Ann Arbor-based Michigan Angel

By |2019-07-23T15:35:57-04:00July 23rd, 2019|Life Sciences|

Biotech firm names chief medical officer

ROYAL OAK — OncoCell MDx has hired Kirk Wojno, M.D., as its chief medical officer. OncoCell MDx is developing new, noninvasive molecular diagnostic assays. Wojno, a renowned urologic pathologist and expert in prostate biopsy interpretation, joins an expanding, experienced executive team. OncoCell MDx also recently announced the appointments of Mark McDonough as president and CEO

By |2019-07-20T14:47:15-04:00July 20th, 2019|Life Sciences|

IDTechEx Research Finds 3D Bioprinted Organ Models Key To $1.9 Billion Market

BOSTON  - There is no doubt that 3D bioprinting is a technology of the future. Imagine being able to print a kidney or liver on demand. This is a stark contrast to the long wait for a donor organ today. Currently, the average wait time for a liver is 4 to 5 months and 2.5

By |2019-07-14T18:19:26-04:00July 14th, 2019|Life Sciences, Life Sciences/Biotech|

OptimizeRx Raises $20 Million In Stock Offering

ROCHESTER—OptimizeRx Corp. (Nasdaq: OPRX), the Rochester-based provider of digital communication services for pharmaceutical companies to patients and healthcare providers, has announced a proposed underwritten public offering of shares of its common stock. The company sold 1,538,500 shares of its common stock at a price of $13 per share. The proceeds of the offering, before deducting

By |2019-06-07T18:51:40-04:00June 7th, 2019|ESD, Life Sciences|

Invest Detroit Ventures Portfolio Client Update: Genomenon

ROYAL OAK - Tember Shea, Portfolio Manager for Invest Detroit Ventures, interviews Mike Klein, CEO of Genomenon, to discuss the latest news coming out of the Ann Arbor-based gene therapy company. Mike Klein  To listen, click on https://soundcloud.com/mike-brennan-841872555/e170-genomenon

By |2019-05-17T11:32:15-04:00May 17th, 2019|Life Sciences, M2 TechCast, Podcasts|

Doctors To Host Forum June 8 In Troy To Provide Evidence Supporting Cannabis’ Medical Efficacy

TROY – A group of Michigan doctors is hosting an all-day forum June 8 in an effort to bridge the conversational gap between healthcare providers, patients and the cannabis industry to provide evidence supporting cannabis’ medical efficacy. “For those interested in gaining knowledge and resources regarding the medical benefits of cannabis, it will be extremely

By |2019-05-08T19:45:52-04:00May 8th, 2019|Life Sciences, News|